Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
T2 Biosystems Inc
TTOO
Healthcare
Biotechnology
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low...
as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TTOO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(280)
•••
whytestocks
X
Post by
whytestocks
on Aug 27, 2024 4:17pm
T2 Biosystems to Participate in the H.C. Wainwright 26th Ann
News; $TTOO T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceLEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), 
...more
(9)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 8:30am
T2 Biosystems, Inc. (NASDAQ:TTOO): Rapid Diagnostics Poised
https://beyondspx.com/2024/08/02/t2-biosystems-inc-nasdaqttoo-rapid-diagnostics-poised-for-significant-growth/
(280)
•••
whytestocks
X
Post by
whytestocks
on Jun 18, 2024 2:45pm
(TTOO) Long Term Investment Analysis
Just In: $TTOO (TTOO) Long Term Investment Analysis2024-06-18 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize
...more
(280)
•••
whytestocks
X
Post by
whytestocks
on Feb 12, 2024 4:45pm
T2 BioSystems stock: brace for TTOO volatility this week
BREAKING NEWS: $TTOO T2 BioSystems stock: brace for TTOO volatility this week2024-02-12 06:34:04 ET T2 BioSystems (NASDAQ: TTOO) stock price has moved from one of the most popular names in Wall Street
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 03, 2023 9:00am
New Press Release - T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
LEXINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming Canaccord Genuity MedTech, Diagnostics and...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 01, 2023 9:00am
New Press Release - T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that on October 31, 2023 it received written notice from the Nasdaq Listing...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 24, 2023 4:05pm
New Press Release - T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
Data demonstrates speed, accuracy, and clinical benefits of the T2Dx Instrument and T2 Biosystems’ sepsis panels, including encouraging early detection data for T2Resistance Panel LEXINGTON, Mass., Oct. 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid...
read article.
(72)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 23, 2023 11:06am
TTOO....You've all been had....again !!!!
Do the math from the RS
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 23, 2023 9:00am
New Press Release - T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the successful amendment and extension to its Term Loan Agreement with CRG Servicing LLC (“CRG...
read article.
(72)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 13, 2023 10:38am
RE:TTOO..... NR this a.m big volume follow up
All that volume and price action was orchestrated for 1 reason......it took 3 months but today the Master Plan was in-acted Does a Leopard ever change its spots What a f'king game
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 12, 2023 4:05pm
New Press Release - T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
Received FDA 510(k) clearance for the T2Biothreat Panel and significantly strengthened balance sheet LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 12, 2023 4:02pm
New Press Release - T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 12, 2023 9:00am
New Press Release - T2 Biosystems Announces Reverse Stock Split Effective Today
TTOO common stock expected to begin trading on a split-adjusted basis on October 13, 2023 LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 06, 2023 4:08pm
New Press Release - T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to nine new employees. The awards were made on October 2, 2023, under the T2 Biosystems...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 05, 2023 4:05pm
New Press Release - T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023
LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report preliminary financial results for the third quarter 2023 and business updates...
read article.
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments
Are PGM mining stocks an attractive area for your next portfolio allocation?